Impairments of long-term potentiation in hippocampal slices of beta-amyloid-infused rats.

[1]  T. Kameyama,et al.  NC-1900, an active fragment analog of arginine vasopressin, improves learning and memory deficits induced by beta-amyloid protein in rats. , 1998, European journal of pharmacology.

[2]  T. Hasegawa,et al.  Continuous infusion of beta-amyloid protein into the rat cerebral ventricle induces learning impairment and neuronal and morphological degeneration. , 1998, Japanese journal of pharmacology.

[3]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Kameyama,et al.  Propentofylline improves learning and memory deficits in rats induced by beta-amyloid protein-(1-40). , 1998, European journal of pharmacology.

[5]  T. Marczynski,et al.  GABAergic Deafferentation Hypothesis of Brain Aging and Alzheimer’s Disease Revisited , 1998, Brain Research Bulletin.

[6]  Charles R. Breese,et al.  Acetylcholine Activates an α-Bungarotoxin-Sensitive Nicotinic Current in Rat Hippocampal Interneurons, But Not Pyramidal Cells , 1998, The Journal of Neuroscience.

[7]  W. K. Cullen,et al.  Block of LTP in rat hippocampus in vivo by β‐amyloid precursor protein fragments , 1997 .

[8]  S. Shimohama,et al.  Nicotinic receptor stimulation protects neurons against β‐amyloid toxicity , 1997 .

[9]  M. Shapiro,et al.  Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein , 1997, Nature.

[10]  R. Gray,et al.  Hippocampal synaptic transmission enhanced by low concentrations of nicotine , 1996, Nature.

[11]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[12]  T. Hasegawa,et al.  Dysfunction of Cholinergic and Dopaminergic Neuronal Systems in β‐Amyloid Protein‐Infused Rats , 1996, Journal of neurochemistry.

[13]  R. Anwyl,et al.  β-amyloid-(1–40) increases long-term potentiation in rat hippocampus in vitro , 1995 .

[14]  L. Role,et al.  Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. , 1995, Science.

[15]  M. Mattson,et al.  Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[16]  K. Davis,et al.  Neurochemical Correlates of Dementia Severity in Alzheimer's Disease: Relative Importance of the Cholinergic Deficits , 1995, Journal of neurochemistry.

[17]  C. Yamamoto,et al.  Long-term potentiation and depression in the dentate gyrus, and effects of nicotine , 1994, Neuroscience Research.

[18]  D L Alkon,et al.  Soluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels. , 1994, Science.

[19]  T. Hasegawa,et al.  β-Amyloid protein-induced Alzheimer's disease animal model , 1994, Neuroscience Letters.

[20]  R. Papke,et al.  A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus , 1994, Neuroscience Letters.

[21]  E. Rojas,et al.  Giant multilevel cation channels formed by Alzheimer disease amyloid beta-protein [A beta P-(1-40)] in bilayer membranes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Mark P. Mattson,et al.  β-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease , 1993, Trends in Neurosciences.

[23]  D. Alkon,et al.  Potassium channel dysfunction in fibroblasts identifies patients with Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Mulle,et al.  Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[25]  S. Younkin,et al.  Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. , 1993, Science.

[26]  E. Rojas,et al.  Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[28]  D. Selkoe,et al.  Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.

[29]  S. Estus,et al.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing. , 1992, Science.

[30]  D. Selkoe,et al.  Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.

[31]  L. Thal,et al.  Solvent effects on beta protein toxicity in vivo , 1992, Neurobiology of Aging.

[32]  Carl W. Cotman,et al.  In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity , 1991, Brain Research.

[33]  J. Hardy,et al.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene , 1991, Nature.

[34]  B. Ghetti,et al.  A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. , 1991, Science.

[35]  Kenneth S. Kosik,et al.  Alzheimer plaques and tangles: advances on both fronts , 1991, Trends in Neurosciences.

[36]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[37]  J. Gray,et al.  Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: Comparison with caudate-putamen , 1990, Neuropharmacology.

[38]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[39]  A. C. Collins,et al.  Nicotine interferes with GABA-mediated inhibitory processes in mouse hippocampus , 1990, Brain Research.

[40]  A. C. Collins,et al.  Evidence for modulation of GABAergic neurotransmission by nicotine , 1988, Brain Research.

[41]  K. Starke,et al.  A Search for Receptors Modulating the Release of γ‐[3H]Aminobutyric Acid in Rabbit Caudate Nucleus Slices , 1986, Journal of neurochemistry.

[42]  C. Pert,et al.  Autoradiographic distribution of nicotine receptors in rat brain , 1984, Brain Research.

[43]  M. Chesselet,et al.  Presynaptic regulation of neurotransmitter release in the brain: Facts and hypothesis , 1984, Neuroscience.

[44]  D L Price,et al.  Alzheimer's disease: a disorder of cortical cholinergic innervation. , 1983, Science.

[45]  D. Neary,et al.  Presynaptic Cholinergic Dysfunction in Patients with Dementia , 1983, Journal of neurochemistry.

[46]  M. Esiri,et al.  Alzheimer's disease Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities , 1982, Journal of the Neurological Sciences.

[47]  J. Coyle,et al.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.

[48]  P. Davies,et al.  SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE , 1976, The Lancet.

[49]  S. Mann,et al.  Ciba Foundation Symposium , 1997 .

[50]  D. Selkoe,et al.  Normal and abnormal biology of the beta-amyloid precursor protein. , 1994, Annual review of neuroscience.

[51]  T. Nabeshima.  Behavioral aspects of cholinergic transmission: role of basal forebrain cholinergic system in learning and memory. , 1993, Progress in brain research.

[52]  P. Sargent,et al.  The diversity of neuronal nicotinic acetylcholine receptors. , 1993, Annual review of neuroscience.

[53]  J. Hardy,et al.  Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.

[54]  A. Drasdo,et al.  Presynaptic nicotinic receptors and the modulation of transmitter release. , 1990, Ciba Foundation symposium.